Rubicon Genomics adds 4 after it pivots business plan
Rubicon Genomics spun out of the University of Michigan in 2000, and the life science start-up hit the rocks a little less than a decade later. Jim Koziarz came in at the end of 2008 and decided to pivot the start-up's business plan. He took it from working to be acquired to working as a viable business. The Ann Arbor-based start-up picked up some in vitro fertilization work in 2009 and used it as a launching pad for its new business model. "That was a very big milestone for the company," says Jim Koziarz, president & CEO of Rubicon Genomics. "We started to generate some sales and dig ourselves out of our hole. It was a turning point." Today Rubicon Genomics is developing and commercializing sample-specific pre-analytical processes to improve the capabilities and performance of DNA and RNA analytical platforms. It has grown its company from a staff of five people in 2009 to a dozen employees and a few independent contractors today. That includes four new hires within the last year when the company broke the $1 million revenue mark. "We will easily double that in 2012," Koziarz says. "The growth is there." He adds the company expects to hire another two researchers this year. Source: Koziarz, president & CEO of Rubicon Genomics Writer: Jon Zemke Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Rubicon Genomics spun out of the University of Michigan in 2000, and the life science start-up hit the rocks a little less than a decade later.
Jim Koziarz came in at the end of 2008 and decided to pivot the start-up’s business plan. He took it from working to be acquired to working as a viable business. The Ann Arbor-based start-up picked up some in vitro fertilization work in 2009 and used it as a launching pad for its new business model.
“That was a very big milestone for the company,” says Jim Koziarz, president & CEO of Rubicon Genomics. “We started to generate some sales and dig ourselves out of our hole. It was a turning point.”
Today Rubicon Genomics is developing and commercializing sample-specific pre-analytical processes to improve the capabilities and performance of DNA and RNA analytical platforms. It has grown its company from a staff of five people in 2009 to a dozen employees and a few independent contractors today. That includes four new hires within the last year when the company broke the $1 million revenue mark.
“We will easily double that in 2012,” Koziarz says. “The growth is there.” He adds the company expects to hire another two researchers this year.
Source: Koziarz, president & CEO of Rubicon Genomics
Writer: Jon Zemke
Read more about Metro Detroit’s growing entrepreneurial ecosystem at SEMichiganStartup.com.
Related Articles
Recast Leaders aim to revitalize local economies
Ypsilanti and six other Michigan communities are working on building their local economies in the Recast Leaders program. Here’s a look at how the program works.
AI’s impact in Washtenaw County, from tech boom to data centers
Our new three-part series digs into AI’s impacts in Ann Arbor’s tech industry, its utilization in Washtenaw County’s educational world, and the ongoing debate about data centers in several Washtenaw County communities.
Ypsi selected to join downtown revitalization program with emphasis on small manufacturers
Ypsilanti is one of six communities participating in Recast City’s Recast Leaders program, which is focused on strengthening local economies through small-scale manufacturing and product-based businesses.
